Navigating Aging

Patients Divided Over Alzheimer’s Drug: Is It a ‘Risk I’m Willing to Take’ or Just a ‘Magic Pill’?

Medicare has proposed limiting coverage of Aduhelm, the costly new drug to treat Alzheimer’s disease, and several prominent groups representing patients and their families are pressing the program to make it more widely available. But among individuals facing the disease, the outlook is more nuanced.

Families Complain as States Require Covid Testing for Nursing Home Visits

Relatives say it is important they be allowed to go into nursing homes because staff shortages are affecting care. And many are still upset about lengthy separations from loved ones during lockdowns earlier in the pandemic.

As Covid Hits Nursing Homes’ Finances, Town Residents Fight to Save Alzheimer’s Facility

Fear of covid has kept some adults from moving to nursing homes, and many facilities are in trouble financially. When Nevada, Missouri, officials announced they were planning to close a home specializing in dementia care, members of the community rose up in protest.

Clarity on Covid Count: Pandemic’s Toll on Seniors Extended Well Beyond Nursing Homes

The latest research shows that although deaths in nursing homes received enormous attention, far more older adults who perished from covid lived outside of institutions. People with dementia and other severe neurological conditions, chronic kidney disease and immune deficiencies were hit especially hard.

Restoring a Sense of Belonging: The Unsung Importance of Casual Relationships for Older Adults

Relationships with people you know only superficially can help develop a sense of belonging and provide motivation to engage in activities. Research has found that older adults who have a broad array of “weak” as well as “close” ties enjoy better physical and psychological well-being and live longer than people with less diverse social networks.

Doctors Weigh Pros and Cons of Prescribing Hot-Button Alzheimer’s Drug

The potential benefits of Aduhelm are small, its effectiveness is not certain, and even the FDA Thursday shifted its guidance on who should get the drug. But physicians are dealing with an onslaught of interest from patients and their families, and figuring out which patients are best positioned to be helped by the drug will be difficult.

Paying Billions for Controversial Alzheimer’s Drug? How About Funding This Instead?

Aduhelm, approved by the Food and Drug Administration last month despite questions about its efficacy, could be prescribed to at least 1 million patients a year, for a price tag of about $56 billion. Experts suggest there might be better ways to spend that money.

Tips for Older Adults to Regain Their Game After Being Cooped Up for More Than a Year

Experts offer advice on how seniors struggling with physical, emotional and cognitive challenges following a year of being cooped up can address issues such as muscle weakness, poor nutrition, disrupted sleep, anxiety and social isolation.